On Friday the 6th of September, Dillico celebrated with our partners and ecosystem a major milestone: the inauguration of our new labs and the presentation of our finalized automatized continuous In Vitro Transcription pilot. This equipment has been developed with the support of i-Lab / France 2030 Grant! ✨
During a facility tour, Dillico’s team took the stage to provide an overview of our digital approach, revolutionary equipment, and analytical platform. This was also the opportunity to share our vision to unleash the potential of mRNA technology thanks to an integrated and all-scale manufacturing platform.
A big shout-out to our teams, subcontractors, and suppliers to contribute to this fast-track development. We can be very proud of this collective technological achievement 👏